跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rahika - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rahika
Approved
STANDARD
Rahika
Novartis Pharma produktions GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5dbfcf08ab7bb750
Company
Novartis Pharma produktions GmbH
Type
Standard
Approval Details
Approval Id
5dbfcf08ab7bb750
Drug Approval Philippines Name
Rahika
Product Name
Rahika
Registration Number
DR-XY48237
Brand Name
Rahika
Generic Name
Capmatinib (As Hydrochloride)
Dosage Form
Film-Coated Tablet
Dosage Strength
200 mg
Manufacturer
Novartis Pharma produktions GmbH
Importer
Novartis Healthcare Philippines, Inc.
Company Detail Path
/organization/novartis-pharma-produktions-gmbh
Issuance Date
29 July 2022
Expiry Date
29 July 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5dbfcf08ab7bb750
Type
Standard
Back to Philippines FDA Approvals